Skip to main content
Premium Trial:

Request an Annual Quote

Gladstone Genomics Core to Standardize on NuGen s Ovation RNA Amplification Kit

NEW YORK, June 29 (GenomeWeb News) - The Genomics Core Laboratory at the J. David Gladstone Institute has chosen NuGen Technologies' Ovation Biotin system as its standard RNA amplification and labeling system, NuGen said today.

 

The J. David Gladstone Institutes, a nonprofit biomedical research institution affiliated with the University of California, San Francisco, will use the Ovation system for small samples to be analyzed on the Affymetrix GeneChip platform, NuGen said.

 

According to Elizabeth Hutt, vice president of sales and technical service at NuGen, the Ovation system requires a 1,000-fold smaller sample than "the previous protocol" in use at the institute, with similar sensitivity and accuracy.

 

NuGen said the system would also reduce the lab's amplification and labeling process from a two- to five-day procedure to one day.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.